$22.3MSeries B, 27 October 2025
Series B funds INNA-051 development including a Phase II community trial in North America.
- Amount
- $22.3M
- Stage
- Series B
- Announced
- 27 October 2025
- Lead
- Brandon Capital
- Other investors
- Uniseed, Stoic Venture Capital, Gates Foundation, Flu Lab
- Use of funds
- Series B funds INNA-051 development including a Phase II community trial in North America.
- Checked
- Amount and date checked against the press source
- Source
- ENA Respiratory raises A$34M Series B smartcompany.com.au